☆ 4.4 Article

Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)

Journal

UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Volume 35, Issue 9, Pages -

Publisher

ELSEVIER SCIENCE INC

DOI: 10.1016/j.urolonc.2017.04.015

Keywords

Bladder cancer; Cell signaling; Wnt; WLS; Chorioallantoic membrane model

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Abstract

Purpose: To analyze the contribution of Wnt signaling pathway to bladder cancer growth in order to identify suitable target molecules for therapy. Material and methods: Expression of Wnt 2/4/7, LRP5/6, TCF1/2/4, LEF-1, and beta-actin was detected by reverse transcription polymerase chain reaction in a panel of 9 and for Wntless (WLS) in 17 bladder cancer cell lines. Protein expression of WLS was detected in 6 cell lines. Wnt/beta-catenin activity was analyzed using the TOPflash/FOPflash luciferase reporter assay. Expression level of beta-catenin, WIF1, Dickkopf proteins (DKK), HSulf-2, sFRP4, and WLS was modulated by transfecting or infecting cells transiently or stably with respective shRNAs, siRNAs, or cDNAs. For protein detection, whole cell lysates were applied to sodium dodecyl sulfate polyacrylamide gel electrophoresis followed by immunoblots. Effects on cell growth were determined by cell viability assays and BrdU/APC incorporation/staining. For 3-dimensional tumor growth, the chicken chorioallantoic membrane model was used. Tumor growth was characterized by weight. Results: Expression of molecular components and activation of the Wnt signaling pathway could be detected in all cell lines. Expression level of beta-catenin, WIF1, DKK, WLS, and HSulf-2 influenced Wnt activity. Expression of WLS was confirmed in 17 cell lines by reverse transcription polymerase chain reaction and in 6 cell lines by immunoblotting. WLS positively regulates Wnt signaling, cell proliferation, and tumor growth in vitro and in vivo. These effects could be reversed by the expression of the Wnt antagonist WIF1 and DKK. Synergistic activity of cisplatin and WLS inactivation by genetic silencing could be observed on cell viability. Conclusion: The Wnt signaling pathway is ubiquitously activated in bladder cancer and regulates tumor growth. WLS might be a target protein for novel therapies in combination with established chemotherapy regimens. (C) 2017 Elsevier Inc. All rights reserved.

Authors

I am an author on this paper

Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4

Not enough ratings

Secondary Ratings

Novelty

Significance

Scientific rigor

Rate this paper

Hypoxia Selectively Increases a SMAD3 Signaling Axis to Promote Cancer Cell Invasion

Karine Brochu-Gaudreau, Martine Charbonneau, Kelly Harper, Claire M. Dubois

Summary: Transforming growth factor beta (TGF beta) has a paradoxical role in cancer, initially inhibiting and then promoting its progression. This study reveals that hypoxia induces the pro-invasive arm of TGF beta signaling through selective activation of SMAD3 and its interaction with SMAD-Anchor for Receptor Activation (SARA). SMAD3 selectively increases the expression of ITGB2 and VIM, genes associated with hypoxia-induced cell invasion, tumor progression, and metastasis. Selective inhibition of the SMAD3 signaling pathway shows significant benefits in preventing tumor progression compared to global TGF beta inhibition.

CANCERS (2022)